MedTrace Logo

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

NCT02523794 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2018-01-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of electro-kinetically modified water (EMW) beverage, consumed twice daily (BID) for 3 months in the management of endometriosis associated pain, and to evaluate the effect of EMW consumption on analgesic use for endometriosis associated pain.

Conditions

  • Pelvic Pain

Interventions

OTHER

Electro-kinetically Modified Water

Subjects assigned to this arm will receive the EMW

OTHER

Placebo

Purified Drinking Water

Sponsors & Collaborators

  • The Geneva Foundation

    collaborator OTHER

  • Revalesio Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523794 on ClinicalTrials.gov